Two Brisbane [Australia] scientists have found a promising new treatment for patients diagnosed with aggressive blood cancer.

Acute myeloid leukaemia (AML) kills about 1,000 Australians each year. Scientists hope human blood cancer trials start soon For most who contract the disease, the prognosis is not good as chemotherapy rarely works. But a team at QIMR Berghofer has found a drug they hope will at least prolong life and perhaps even beat the disease.

Dr Steven Lane, head of the Translational Leukaemia Research Laboratory, said in pre-clinical studies the drug Imetelstat inhibited the protein needed for the formation of the leukaemia stem cells.

Dr Steven Lane: "The first group of patients we want to help is those patients who can't have chemotherapy. The study found that by turning off a gene called telomerase, the cancer cells become unstable and eventually the cells die," Tests also found that Imetelstat delayed or prevented relapse of AML following chemotherapy.

Dr Lane and colleague Dr Claudia Breudigam presented their findings to the American Society of Haemotology in San Fransisco, which were recently published in a peer-reviewed publication. Imetelstat is undergoing clinical trials for other blood cancers in the US.

The US Food and Drug Administration has just lifted a hold on the drug after concerns it caused liver toxicity were remedied. Dr Lane said authorities had to weigh the risks and benefits. Imetelstat is undergoing clinical trials for other blood cancers in the US.

Ted Hiller was diagnosed with acute myeloid leukaemia seven months ago. Ted Hillier said people had to be prepared to take a risk with the trials.

More at http://www.abc.net.au/news/2014-12-05/blood-c...ugh-in-queensland/5947660

Is it similar to MCM1 project??

Genomic Data Commons: Expanded access to large-scale cancer genomic data.
The University of Chicago in Illinois, US, is collaborating with the US National Cancer Institute (NCI) to establish the nation’s most comprehensive computational facility, storing cancer genomic data generated through NCI-funded research programs.
The NCI Genomic Data Commons (GDC) will expand access for scientists, speeding up research and leading to faster discoveries for patients. Providing an interactive system for researchers, the GDC will make the data easier to use. It will also provide resources to facilitate the identification of subtypes of cancer as well as potential therapeutic targets.
http://www.isgtw.org/feature/genomic-data-com...a?nocache=1#comment-43212

Australian radio interview on the use of MRI for accurate diagnosis and possibly treatment of prostate cancer, with higher accuracy and lower false positives, fewer needles.

http://www.abc.net.au/radionational/programs/...-a-game-changer3f/5967568

Note the Transcript buttons.

NOT"JUST BACK LUCK"

Here just a scientific answer to that partial US study; questioning the
methodology and conclusions
sorry it is in french,but the only answer from scientists i have found

Denial from the french CIRC:

Cancer, la faute à « pas de chance » ? Le CIRC dément

New report says all Cancers will die off by 2050

A new report has drawn quite a bit of attention with its eye-popping prediction that by as early as 2050 no one under 80 will experience cancer.

The claim is tremendous, but the researchers from University College London (UCL) and Kings's College London say they have the science to back it up
.

http://www.msn.com/en-us/health/medical/new-r...ie-off-by-2050/ar-AA8fN9F